This early-stage trial is testing whether a single same-day treatment using a patient's own bone marrow cells is safe and tolerable for people with Parkinson's disease or related conditions. The procedure involves drawing bone marrow from the hip, giving one portion through an IV…
Phase: PHASE1, PHASE2 • Sponsor: Apeiron Research Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC